| Company Name | # of Hedge Funds | # of Insiders Buying | # of Insiders Selling |
| Merck & Co., Inc. (NYSE:MRK) | 65 | 0 | 4 |
| GlaxoSmithKline plc (ADR) (NYSE:GSK) | 21 | 0 | 0 |
| Bristol Myers Squibb Co. (NYSE:BMY) | 43 | 0 | 12 |
| AstraZeneca plc (ADR) (NYSE:AZN) | 17 | 0 | 0 |
| AbbVie Inc (NYSE:ABBV) | 41 | 1 | 3 |
Using the returns shown by our analyses, regular investors should always keep one eye on hedge fund and insider trading activity, and Eli Lilly & Co. (NYSE:LLY) shareholders fit into this picture quite nicely.
Discover how hedge fund piggybacking can benefit you